Svein Olav Bratlie

Sahlgrenska University Hospital

Papers

5

Total Citations

200

H-Index

5

About

Svein Olav Bratlie is a leading surgical oncologist whose research focuses on advancing minimally invasive pancreatic surgery, particularly for pancreatic ductal adenocarcinoma. His most impactful contribution is the landmark DIPLOMA trial, an international randomised non-inferiority study that compared minimally invasive distal pancreatectomy (MIDP) with open surgery for resectable pancreatic cancer. This work, published in 2023 and already cited over 120 times, provided crucial evidence on the oncological safety of the minimally invasive approach. Bratlie also co-authored the DIPLOMA study protocol and has been instrumental in establishing the European E-MIPS registry, which tracks outcomes of minimally invasive pancreatic surgery across Europe. His recent 2025 publication extends the DIPLOMA findings to long-term survival data. Through these efforts, Bratlie has helped shape international guidelines and surgical practice, demonstrating that minimally invasive techniques can achieve comparable radical resection rates while potentially improving recovery. His work is essential reading for any surgeon or researcher interested in evidence-based pancreatic cancer care and the evolution of minimally invasive surgical oncology.

Research Focus

Key Achievements

5
H-Index
5
Papers
200
Total Citations
40
Avg Citations/Paper
🏆 Most Cited Paper
Minimally invasive versus open distal pancreatectomy for resectable pancreatic cancer (DIPLOMA): an international randomised non-inferiority trial
121 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 167
🏛 Institutions: Sahlgrenska University Hospital

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago